The delegation, led by Alisher Temirov, Director of the Center for Pharmaceutical Products Safety, Uzbekistan, had detailed discussions with Ranga Chandrashekar, Joint Drugs Controller of India ...

VTDigger publishes a variety of stories on public safety, including crime, the court system, fire and EMS, law enforcement and prisons. Sign up to receive our free weekly roundup of public safety ...

Pharmaceutical companies are often lambasted for rising drug costs. For example, the price of new drugs entering the US market in 2023 was 35% higher than in 2022. According to an analysis from ...

In the modern world, where the rules and regulations are very strict, labeling is not just a luxury but a necessity. There is ...

Shifting”, “Trojan Horse”, Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR ...

Shares of Strides Pharma Science Ltd are in focus on Wednesday morning after the drugmaker said its associate company, OneSource Specialty Pharma, has received confirmed commitments for ...

The U.S. Drug Enforcement Administration (DEA) has identified and put out an alert on several illegal online pharmacies that ...

There was initially this fear about hormone therapy. Then it became radio silence on the whole topic of women's health” ...

The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug WASHINGTON -- The Supreme Court on Monday ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that twelve presentations following expansive research in amyotrophic lateral sclerosis (ALS) will be shared as part of the Northeast ...

ClorNovir uses chlorpheniramine, an H1 antagonist, delivered via award winning GentleMist Technology™ for targeted nasal application. By addressing the viral replication site in the nasopharyngeal ...

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – NMD Pharma A/S, a clinical-stage ...